Adolesc Med 17 (2006) 283 – 318

Adolescent Abuse of Other Drugs
Jeffery P. Greene, MDa,T, Dale Ahrendt, MDb, Elisabeth M. Stafford, MDa a Adolescent Medicine Section, San Antonio Military Pediatric Center, Brooke Army Medical Center, 3851 Roger Brooke Drive, Fort Sam Houston, TX 78234, USA b Uniformed Services University of the Health Sciences, Wilford Hall Air Force Medical Center, 859 MDOS/MMNP, 2200 Berquist Drive, Suite 1, Lackland AFB, TX 78236, USA

This article provides a general overview of other drugs of abuse within the adolescent population. Stimulants, hallucinogens, club drugs, inhalants, sedativehypnotics, tranquilizers, opiates, and ergogenic drugs are included. Epidemiology, pharmacology, clinical aspects, …ver más…

Availability of such prescription medications by the Internet makes this more problematic. Clinicians must be sensitive to the potential for drug seeking as adolescents and their parents present

ADOLESCENT ABUSE OF OTHER DRUGS

285

Table 1 Illicit drug use in lifetime, past year, and past month among persons aged 12 to 17: percentages, 2002 and 2003 Time period Lifetime Drug Any illicit drug Marijuana and hashish Cocaine Crack Heroin Hallucinogens LSD PCP Ecstasy Inhalants Nonmedical use of any psychotherapeuticc Pain relievers Tranquilizers Stimulants Methamphetamine Sedatives Any illicit drug other than marijuana 2002 30.9 20.6a 2.7 0.7 0.4 5.7b 2.7b 0.9 3.3b 10.5 13.7 11.2 3.4 4.3 1.5 1.0 21.4 2003 30.5 19.6 2.6 0.6 0.3 5.0 1.6 0.8 2.4 10.7 13.4 11.2 3.5 4.0 1.3 1.0 21.3 Past year 2002 22.2 15.8 2.1 0.4 0.2 3.8b 1.3b 0.4 2.2b 4.4 9.2 7.6 2.3 2.6 0.9a 0.6 13.5 2003 21.8 15.0 1.8 0.4 0.1 3.1 0.6 0.4 1.3 4.5 9.2 7.7 2.3 2.3 0.7 0.5 13.4 Past month 2002 11.6 8.2 0.6 0.1 0.0 1.0 0.2 0.1 0.5 1.2 4.0 3.2 0.8 0.8 0.3 0.2 5.7 2003 11.2 7.9 0.6 0.1 0.1 1.0 0.2 0.1 0.4 1.3 4.0 3.2 0.9 0.9 0.3 0.2 5.7

Abbreviations: LSD, lysergic acid diethylamide; PCP, phenycyclidine. a Difference between estimate and 2003 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2003 estimate is statistically significant at the 0.01 level. c Nonmedical use of any prescription-type pain reliever, tranquilizer,